
Sign up to save your podcasts
Or
This is the second episode of a two-part educational series to raise awareness of epidermolysis bullosa (EB) and the latest FDA-approved treatment options for this disease. Our host, Dr. Michael Lavery, a Pediatric Dermatologist and Clinical Assistant Professor at the University of Florida in Gainesville, FL, is joined by Dr. Joyce Teng, MD, PhD, Professor of Dermatology and Pediatrics at Stanford University School of Medicine in Stanford, CA, as they discuss the following topics:
Setting the stage for treating a patient with EB
Assessing EB severity and subtype to inform treatment
Expert review of the current FDA-approved treatments and
Strategies to close care gaps for EB patients
5
66 ratings
This is the second episode of a two-part educational series to raise awareness of epidermolysis bullosa (EB) and the latest FDA-approved treatment options for this disease. Our host, Dr. Michael Lavery, a Pediatric Dermatologist and Clinical Assistant Professor at the University of Florida in Gainesville, FL, is joined by Dr. Joyce Teng, MD, PhD, Professor of Dermatology and Pediatrics at Stanford University School of Medicine in Stanford, CA, as they discuss the following topics:
Setting the stage for treating a patient with EB
Assessing EB severity and subtype to inform treatment
Expert review of the current FDA-approved treatments and
Strategies to close care gaps for EB patients
131 Listeners
25,594 Listeners
111,917 Listeners
1,124 Listeners
18 Listeners
7,953 Listeners
185 Listeners
35 Listeners
134 Listeners
28,473 Listeners
47 Listeners
4 Listeners
82 Listeners
4 Listeners
27 Listeners